Wire flash
Geodesic Intelligence launches with AGI-for-drug-discovery goal, unveils NovaDDE and NovaAtom-Lite-Preview
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
Geodesic Intelligence, a new venture introduced by Quanquan Gu, announced its launch with the ambitious goal of building artificial general intelligence (AGI) specifically for drug discovery, aiming to find the shortest path from biology to medicines. The company is integrating frontier AI, biological foundation models, and experimental science to create a full-stack system from intelligence to medicines. Concurrent with its introduction, Geodesic Intelligence released two products: NovaDDE and NovaAtom-Lite-Preview. The founder expressed excitement about the launch, describing it as just the beginning of the company's efforts.
Source report
I’m incredibly excited to finally introduce Geodesic Intelligence (@Geodesiclab).
We started Geodesic with an ambitious goal: build AGI for drug discovery and find the shortest path from biology to medicines.
We’re bringing together frontier AI, biological foundation models, and experimental science, and building the full stack from intelligence to medicines.
Today’s Launch
Today, we’re launching NovaDDE and NovaAtom-Lite-Preview.
This is just the beginning.
Source
QuanquanGuNeutral / independent